top of page
Search Results

461 items found for "G-protein coupled receptor signaling"

  • Residency time of agonists does not affect the stability of GPCR-arrestin complexes

    September 2022 " Background and purpose: The interaction of arrestins with G-protein coupled receptors (GPCRs) desensitizes agonist-dependent receptor responses and often leads to receptor internalization The interaction of arrestins with GPCRs requires both agonist activation and receptor phosphorylation the question whether agonists with very slow off-rates can cause the formation of particularly stable receptor-arrestin

  • Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR

    The study distinguishes between driver residues , which directly influence signal transduction, and modulator By pinpointing the molecular determinants of ligand efficacy and potency in GPCR signalling, this research These insights have the potential to advance the treatment of various diseases involving GPCR signalling Molecular determinants of ligand efficacy and potency in GPCR signaling. Molecular basis of proton-sensing by G protein-coupled receptors. bioRxiv .

  • GRK2 in cardiovascular disease and its potential as a therapeutic target

    G protein-coupled receptors (GPCRs) are critical myocardial signal transducers which regulate cardiac models of cardiac pathology, and most pharmacological therapeutics currently used in HF target these receptors A recent focus on GPCR intracellular-regulating proteins such as GPCR kinases (GRKs) has uncovered GRK2 Additionally, the GRK2 interactome includes numerous proteins which interact with differential domains of GRK2 to modulate both beneficial and deleterious signaling pathways in the heart, indicating that

  • PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design

    October 2022 "While the role of G-protein-coupled receptors (GPCR) in cancer is acknowledged, their underlying signaling pathways are understudied. Protease-activated receptors (PAR), a subgroup of GPCRs, form a family of four members (PAR1-4) centrally In addition to PH-Akt/PKB association, other PH-containing signal proteins such as Gab1 and Sos1 also AYPGKF peptide ligand activation of PAR4 induces EGF receptor (EGFR) Tyr-phosphorylation, effectively

  • 📰 GPCR Weekly News, October 2 to 8, 2023

    Taste GPRASP1 loss-of-function links to arteriovenous malformations by endothelial activating GPR4 signals GPCRs in Neuroscience Involvement of a silkworm D2-like dopamine receptor in the promotion of feeding and Molecular Insights into GPCR Function Interplay of Cholesterol and Actin in Neurotransmitter GPCR Signaling selectivity Industry News Sosei Heptares and Verily Nominate First G-protein-coupled receptor Target Molecular Secures Nearly $900K in NIH Funding to Discover Antibodies Against Difficult and Conserved Protein

  • Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinet

    protein-coupled receptors (GPCRs) are an important receptor superfamily and common therapeutic targets The second messenger cyclic adenosine monophosphate (cAMP) is a key mediator in many GPCR signaling pathways In this regard, luminescence-based biosensors have revolutionized our ability to monitor GPCR signaling The GloSensor™ cAMP assay enables real-time monitoring of signaling downstream of many GPCRs. Nevertheless, the GloSensor™ cAMP assay can be applied to analyze signaling by a wide range of GPCRs

  • 📰 GPCR Weekly News, February 27 to March 5, 2023

    G protein. Developing novel antifungals: lessons from G protein-coupled receptors. Biosciences won Top Out-Licensing Deal on the 8th annual Japan Deal of the Year Call for GPCR Papers GPCRs: Signal (June 11 - 16, 2023). 11th Adrenoceptor Symposium: Adrenoceptors and GPCR Signalling (June 30 - July Integrated Approaches In Pharmacology, Computer Simulations And Machine Learning To Predict Ligand Signaling

  • Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies

    September 2022 "Research on cancer therapies focuses on processes such as angiogenesis, cell signaling In 2008 (and for the first time in the clinic), the therapeutic benefits of the β-adrenergic receptor

  • 📰 GPCR Weekly News, February 13 to 19, 2023

    GPCR Activation and Signaling Statins inhibit protein kinase D (PKD) activation in intestinal cells and Anionic phospholipids control mechanisms of GPCR-G protein recognition. From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction. Reviews, GPCRs, and more Single nucleotide variations encoding missense mutations in G protein-coupled Artificial Intelligence for Drug Discovery Call for GPCR Papers GPCRs: Signal Transduction.

  • 📰 GPCR Weekly News, February 20 to 26, 2023

    GPCR Activation and Signaling Coupling between GPR143 and dopamine D2 receptor is required for selective All-Atom Molecular Dynamics Simulations Indicated the Involvement of a Conserved Polar Signaling Channel Impact of membrane lipid polyunsaturation on dopamine D2 receptor ligand binding and signaling GPCR Binders Small-molecule targeting of GPCR-independent non-canonical G protein signaling inhibits cancer progression of schizophrenia Call for GPCR Papers GPCRs: Signal Transduction.

  • GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...

    cancer cells and decreases their response to paclitaxel by forming a vicious cycle with IGF1/IGF1R signaling pathway "There is a potential correlation between G-protein-coupled receptor-associated sorting protein Mechanistically, GASP1 inhibited proteasomal degradation of insulin-like growth factor 1 receptor (IGF1R by competitively binding to IGF1R with ubiquitin E3 ligase MDM2, thereby activating its downstream signaling

  • 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!

    Let’s dive into the   Classified GPCR News  from August 19th to 25th, 2024 GPCR Activation and Signaling Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling of Mammary Epithelial Cells through the GPR37-mTOR-S6K1 Signaling GPCRs in Neuroscience Astrocyte Gi-GPCR signaling corrects compulsive-like grooming and anxiety-related behaviors in Sapap3 knockout mice Methods & Updates in GPCR Research Genome-wide identification of 769 G protein-coupled receptor (GPCR) genes

  • Harnessing Deep Mutational Scanning for Enhanced Drug Discovery

    The result suggested that, in contrast to other proton-sensitive channels and receptors, GPR68 did not Additionally, DMS is not universally applicable to all proteins; it struggles with proteins that lack Deep mutational scanning: assessing protein function on a massive scale. G., Coyote-Maestas, W., & Aashish Manglik. (2024). Molecular basis of proton-sensing by G protein-coupled receptors.

  • Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs

    June 2022 "G protein-coupled receptors (GPCRs) represent a major therapeutic target class as they play GPCRs respond to a wide variety of signals that range in size from photons to proteins (Foord et al.,

  • Increased Anxiety-like Behaviors in Adgra1-/- Male But Not Female Mice are Attributable to...

    Upregulated PSD95 Expression, and Abnormal Activation of the PI3K/AKT/GSK-3β and MEK/ERK Pathways "Adhesion G protein-coupled receptor A1 (ADGRA1) belongs to the G protein-coupled receptor (GPCR) family, and its

  • Aβ peptides stabilize GPCRs in inactive form and trigger inverse agonism in Alzheimer's disease

    August 2022 "Several G-protein coupled receptors (GPCR) are upregulated in Alzheimer's Disease (AD),

  • Production of human A2AAR in lipid nanodiscs for 19F-NMR and single-molecule fluorescence...

    F-NMR and single-molecule fluorescence spectroscopy "We describe production of the human A2A adenosine receptor (A2AAR), a class A G protein-coupled receptor (GPCR) for 19F-NMR and single-molecule fluorescence (SMF

  • 📰 GPCR Weekly News, March 13 to 19, 2023

    GPCR Activation and Signaling Components of TOR and MAP kinase signaling control chemotropism and pathogenicity A Rab10-ACAP1-Arf6 GTPases cascade modulates M4 muscarinic acetylcholine receptor trafficking and signaling G protein-coupled receptor pharmacology - insights from mass spectrometry. (June 28 - 30, 2023) 11th Adrenoceptor Symposium: Adrenoceptors and GPCR Signalling (June 30 - July 1 Associate Scientist, Protein Science. Explore Dr. GPCR Ecosystem

  • Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembra

    G protein-coupled receptors (GPCRs) are among the most promising drug targets. They often form homo- and heterodimers with allosteric cross-talk between receptor entities, which contributes to fine-tuning of transmembrane signaling. modulators (PAMs) that bind at the interface of the transmembrane domains of the heterodimeric GABAB receptor core of the GABAB2 transmembrane domain, which also controls the constitutive activity of the GABAB receptor

  • 📰 GPCR Weekly News, September 4 to 10, 2023

    galactose-binding lectin domain involved in the innate immune response of Tribolium castaneum GPCR Activation and Signaling Strategies and Biological Studies of These Emerging Cannabinoid Analogs GPCRs in Neuroscience Serotonin signaling agonist binding Structural and Molecular Insights into GPCR Function Structure and Molecular Mechanism of Signaling for the Glucagon-like Peptide-1 Receptor Bound to Gs Protein and Exendin-P5 Biased Agonist Molecular , 2023 | Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric Function and Biased Signaling

  • 📰 GPCR Weekly News - January 2 to 8, 2023

    GPCR Activation and Signaling Signal Transduction and Gene Regulation in the Endothelium. GPCR Signaling Measurement and Drug Profiling with an Automated Live-Cell Microscopy System. GPCRs in Oncology and Immunology Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer STALICLA signs agreement with Novartis on neurodevelopmental disorders Call for GPCR Papers GPCRs: Signal Deadline February 12, 2023 Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology

  • Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..

    Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases "The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies, in particular autoimmune diseases.

  • Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist

    30, 2021 -- Orion Biotechnology , a clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class OB-004 is a GPCR targeted protein analog of CCL2 that targets the CCR2 receptor.

  • 📰 GPCR Weekly News, January 22 to 28, 2024

    GPCR Symposia Our first upcoming symposium on March 15th this year is about GPCR activation and signaling Let’s dive into the Classified GPCR News from January 22nd to 28th, 2024 GPCR Activation and Signaling analysis of α-arrestin families in human and Drosophila Functional diversification of cell signaling Oncology and Immunology Molecular docking and dynamics simulation studies uncover the host-pathogen protein-protein and Exhibition June 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein

  • GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...

    Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A2A Adenosine Receptor "Modulators of the G protein-coupled A2A adenosine receptor (A2AAR) have been considered promising agents Structural analysis revealed that the introduced thiophene modification restricted receptor conformational This approach can expand the repertoire of adenosine receptor antagonists that can be designed based

  • Engineered synaptic tools reveal localized cAMP signaling in synapse assembly

    Although numerous signals are known to regulate synapses, it remains unclear which signaling mechanisms referred to as "SynTAMs" for synaptic targeting molecules, that enable localized perturbations of cAMP signaling We show that locally restricted suppression of postsynaptic cAMP levels or of cAMP-dependent protein-kinase In vivo, suppression of postsynaptic cAMP signaling in CA1 neurons prevented formation of both Schaffer-collateral Retrograde trans-synaptic rabies virus tracing revealed that postsynaptic cAMP signaling is required

  • Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of...

    Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs "A growing number of G-protein-coupled receptor (GPCR) structures reveal novel transmembrane lipid-exposed allosteric sites. in the access and binding of ORG27569 and its analogs at the transmembrane site of cannabinoid CB1 receptor

  • A broad look into the future of systemic sclerosis

    Abs against the angiotensin II receptor subtype 1 (AT1R) and the endothelin receptor type A (ETAR) are Promising nuclear receptors as key regulators of transcriptional programmes will be introduced as well Fibroblasts from SSc patients exhibit a specific signalling and reactivate developmental pathways and Pharmacological interventions, although for other indications, are already in clinical use to address pathologic signalling

bottom of page